Creative Capital Management Investments’s Dyne Therapeutics DYN Stock Holding History

Creative Capital Management Investments’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$178	Buy	+8	New	+$149	﹤0.01%	1396

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Creative Capital Management Investments's DYN Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 8 shares worth $178. The stake represents ﹤0.01% of the portfolio and ranks #1396 among its holdings.

245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

Creative Capital Management Investments held 8 shares of Dyne Therapeutics worth $178 as of Q2 2026.
Dyne Therapeutics was a new Creative Capital Management Investments position in Q2 2026.
Dyne Therapeutics made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1396 holding.
245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.